Openbookopenbook
Equity
STEX
+0.0 · +0.00%
USD · NASDAQ

Streamex Corp(STEX) Stock Analysis | Financial Services

USD --+0.00%
Reward46Moderate
Risk85High
75%Data
Speculative Momentum
Market Cap:174.07M
ⓘ
Reward Rating
46
Moderate
Reward Assessment
75% data coverage
Bottom 25% of stocksView factors
ⓘ
Risk Rating
85
High
Risk Assessment
7 metrics flaggedView details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on STEX to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
New listing — limited trading history
Fundamental and analyst data are available for STEX, but momentum and volatility metrics will develop as more trading history accumulates (0 trading sessions so far).
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $4.00.

What is Streamex Corp?

, a medical device technology company, provides advanced digital signal processing solutions for electrophysiology in the United States.

STEX · Verdict

Moderate reward · high risk

STEX has limited near-term tailwinds — volatility and profitability weigh on the model output.

Based on 88% data coverage

STEX · Verdict

What’s working & what to watch

Watchouts 4

  • Volatility5/100

    Weak vs peers

  • Profitability10/100

    -697% return on equity

  • Cash flow17/100

    Weak vs peers

  • Balance sheet22/100

    Current ratio 1.68

Model-based scoring. For information only — not financial advice.

What is Streamex Corp?

, a medical device technology company, provides advanced digital signal processing solutions for electrophysiology in the United States. The company offers the PURE EP platform, which delivers cardiac signal data to electrophysiologists during ablation procedures for the treatment of cardiovascular arrhythmias. The company is listed on the NASDAQ in USA, operating in the Financial Services sector, with a market capitalisation of 174.07M.

Financial Highlights

Investment Breakdown

Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
Profitability
Thin or inconsistent margins weigh on earnings quality.
Risk
Elevated volatility implies higher downside and expectation risk.
Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (46)

The scoring profile indicates limited reward potential at this time, with growth and valuation offering the most support. Risk indicators are high — this profile reflects meaningful downside exposure.

For informational purposes only. Not financial advice.

Similar stocks to compare

A short list of Capital Markets names that are close enough in size to make side-by-side comparison useful.

BMHLMicro Cap / 153M market cap
Bluemount Holdings Limited Class B Ordinary Shares
Compare
XAUMFMicro Cap / 150M market cap
GoldMoney Inc
Compare
BRRMicro Cap / 148M market cap
ProCap Financial, Inc.
Compare
Company Information
SectorFinancial Services
IndustryCapital Markets
Market Cap174.07M
P/E RatioN/A
Dividend YieldN/A
Beta2.017
Insider Activity
12M windowBullish
Shares soldShares bought
0-3months
0
0
3-6months
456,873 shares
$61k
0
6-9months
0
91,267,011 shares
$3.8M
9-12months
0
0
openbook

Stock research for UK and US investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.